Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCORI Initiates A Targeted Approach To Research At November Meeting

Executive Summary

In a departure from asking researchers to propose specific research topics within broadly defined areas, the board of the Patient-Centered Outcomes Research Institute approved a plan to fund research in three targeted areas – treatment of uterine fibroids, management of asthma in African-Americans and prevention of falls in the elderly – and up to two additional areas.

You may also be interested in...



PCORI Board Ponders Plan For More “Focused” Research

Patient-Centered Outcomes Research Institute staff’s plan to make investigator-initiated research more focused brings out board members’ concerns about whether the institute can meet its aim of providing research that helps stakeholders make more informed decisions about health care.

Inflammatory Bowel Drugs To Go Head-To-Head With PCORI Funding

A number of drug-related comparative effectiveness research projects are approved for PCORI-sponsored research in its second funding cycle. Health IT-related projects also get attention as the institute spends more than $88 million on 51 projects.

Research Funding To Dominate PCORI’s Agenda In 2013

The continued funding of research, as well as supporting activities associated with that research, will be the primary focus of the Patient-Centered Outcomes Research Institute’s activities in 2013.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054939

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel